Public health and valorization of genome-based technologies: a new model
<p>Abstract</p> <p>Background</p> <p>The success rate of timely translation of genome-based technologies to commercially feasible products/services with applicability in health care systems is significantly low. We identified both industry and scientists neglect health...
Main Authors: | Lal Jonathan A, Schulte in den Bäumen Tobias, Morré Servaas A, Brand Angela |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-12-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://www.translational-medicine.com/content/9/1/207 |
Similar Items
-
Use of Genomic Information in Health Impact Assessment Is Yet to Come: A Systematic Review
by: Balázs Ádám, et al.
Published: (2020-12-01) -
Analysis of existing international policy evidence in public health genomics: mapping exercise
by: Elena V. Syurina, et al.
Published: (2012-02-01) -
Impact assessment of Iran’s health technology assessment programme
by: Bahareh Yazdizadeh, et al.
Published: (2018-02-01) -
Structured Q1 headache services as the solution to the ill-health burden of headache: 1. Rationale and description
by: Timothy J. Steiner, et al.
Published: (2021-07-01) -
Assessing the performance of health technology assessment (HTA) agencies: developing a multi-country, multi-stakeholder, and multi-dimensional framework to explore mechanisms of impact
by: Robyn Millar, et al.
Published: (2021-07-01)